v3.25.4
INTERIM CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - CAD ($)
Capital Stock
Cogent Asset acquisition
Capital Stock
OrangeFin Asset acquisition
Capital Stock
Reserves
Cogent Asset acquisition
Reserves
OrangeFin Asset acquisition
Reserves
Accumulated Other Comprehensive (Loss) Income
Deficit
Total
Balance at the beginning at Sep. 30, 2024     $ 17,256,668     $ 17,297,454 $ 2,540,513 $ (10,371,011) $ 26,723,624
Balance at the beginning (in shares) at Sep. 30, 2024     18,271,711            
Share based compensation           7,862,418     7,862,418
Options exercised     $ 1,765,033           $ 1,765,033
Options exercised (in shares)     1,698,476           1,698,476
Fair value of options exercised     $ 1,355,639     (1,355,639)      
Warrants issued for acquisitions           7,428,729     $ 7,428,729
Warrants exercised     $ 9,046,670           $ 9,046,670
Warrants exercised (in shares)     452,333           452,333
Fair value of warrants exercised     $ 2,172,892     (2,172,892)      
Shares issued for acquisitions     $ 22,330,215     (3,718,400)     $ 18,611,815
Shares issued for acquisitions (in shares)     1,283,849           1,283,849
Shares to be issued for acquisitions           42,777,295     $ 42,777,295
RSUs converted for shares     $ 2,882,142     (2,882,142)     $ 2,882,142
RSUs converted for shares (in shares)     124,103           124,103
Interest paid with common shares     $ 371,891           $ 371,891
Interest paid with common shares (in shares)     21,563           21,563
Convertible debenture, equity component           7,205,608     $ 7,205,608
Shares issued upon conversion of convertible debt     $ 13,247,405           $ 13,247,405
Shares issued upon conversion of convertible debt (in shares)     1,147,806           1,147,806
Net loss for the year               (35,035,126) $ (35,035,126)
Transfer of historical unrealized gains on disposal of Bitcoin             1,733,197 (1,733,197)  
Other comprehensive income             14,775,291   14,775,291
Balance at the ending at Sep. 30, 2025     $ 70,428,555     72,442,431 19,049,001 (47,139,334) 114,780,653
Balance at the ending (in shares) at Sep. 30, 2025     22,999,841            
Share based compensation           1,276,413     $ 1,276,413
Shares issued for acquisitions $ 3,718,400 $ 1,093,379   $ (3,718,400) $ (1,093,379)        
Shares issued for acquisitions (in shares) 387,333 533,216             920,549
Shares issued upon conversion of convertible debt     $ 1,259,276           $ 1,259,276
Shares issued upon conversion of convertible debt (in shares)     290,094           290,094
Units issued for LIFE offering     $ 30,003,000           $ 30,003,000
Units issued for LIFE offering (in shares)     4,380,000            
Warrant value on the LIFE offering     $ (17,912,000)     17,912,000     17,912,000
Share issue costs (commissions)     (1,800,180)           (1,800,180)
Share issue costs (warrants)     (1,075,000)     1,075,000     (1,075,000)
Share issue costs (legal)     (336,879)           (336,879)
Net loss for the year               (11,846,638) (11,846,638)
Other comprehensive income             (53,517,293)   (53,517,293)
Balance at the ending at Dec. 31, 2025     $ 85,378,551     $ 87,894,065 $ (34,468,292) $ (58,985,972) $ 79,818,352
Balance at the ending (in shares) at Dec. 31, 2025     28,590,484